These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22742527)

  • 1. Decrease in anti-Leishmania IgG3 and IgG1 after cutaneous leishmaniasis lesion healing is correlated with the time of clinical cure.
    Fagundes-Silva GA; Vieira-Goncalves R; Nepomuceno MP; de Souza MA; Favoreto S; Oliveira-Neto MP; Da-Cruz AM; Gomes-Silva A
    Parasite Immunol; 2012 Oct; 34(10):486-91. PubMed ID: 22742527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of ELISA employing Leishmania (Viannia) braziliensis and Leishmania (Leishmania) chagasi antigens for the detection of IgG and IgG1 and IgG2 subclasses in the diagnosis of American tegumentary leishmaniasis in dogs.
    Ribeiro FC; de O Schubach A; Mouta-Confort E; Schubach TM; de Fátima Madeira M; Marzochi MC
    Vet Parasitol; 2007 Sep; 148(3-4):200-6. PubMed ID: 17689193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of anti-lived and anti-fixed Leishmania (Viannia) braziliensis promastigote IgG antibodies detected by flow cytometry for diagnosis and post-therapeutic cure assessment in localized cutaneous leishmaniasis.
    Pereira VR; Reis Lde C; Souza Mde A; de Oliveira AP; de Brito ME; Lage PS; Andrade MC; Rocha RD; Martins-Filho OA
    Diagn Microbiol Infect Dis; 2012 Nov; 74(3):292-8. PubMed ID: 23007034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of flow cytometry and indirect immunofluorescence assay in the diagnosis and cure criterion after therapy of American tegumentary leishmaniasis by anti-live Leishmania (Viannia) braziliensis immunoglobulin G.
    de Oliveira AP; de Castro MC; de Almeida AF; Souza Mde A; de Oliveira BC; Reis LC; Goto H; de Brito ME; Celeste BJ; Martins-Filho OA; Pereira VR
    J Immunol Methods; 2013 Jan; 387(1-2):245-53. PubMed ID: 23142460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.
    Romero GA; de la Glória Orge Orge M; de Farias Guerra MV; Paes MG; de Oliveira Macêdo V; de Carvalho EM
    Acta Trop; 2005 Jan; 93(1):49-56. PubMed ID: 15589797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunoglobulin isotype and IgG subclass profiles in American tegumentary leishmaniasis].
    de Souza MA; da Silva AG; Afonso-Cardoso SR; Favoreto SJ; Ferreira MS
    Rev Soc Bras Med Trop; 2005; 38(2):137-41. PubMed ID: 15821787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of anti-live Leishmania (Viannia) braziliensis immunoglobulin G subclasses, detected by flow cytometry, for diagnosing active localized cutaneous leishmaniasis.
    Rocha RD; Gontijo CM; Elói-Santos SM; Teixeira-Carvalho A; Corrêa-Oliveira R; Ferrari TC; Marques MJ; Mayrink W; Martins-Filho OA
    Trop Med Int Health; 2006 Feb; 11(2):156-66. PubMed ID: 16451339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Leishmania chagasi immunoglobulin G3 detected by flow cytometry for early cure assessment in American visceral leishmaniasis.
    Gomes IT; Carvalho SF; Rocha RD; Peruhype-Magalhães V; Dietze R; Martins-Filho OA; Lemos EM
    J Immunol Methods; 2010 Aug; 360(1-2):76-83. PubMed ID: 20598707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production.
    Castellano LR; Filho DC; Argiro L; Dessein H; Prata A; Dessein A; Rodrigues V
    Hum Immunol; 2009 Jun; 70(6):383-90. PubMed ID: 19480861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody subclass profile against Leishmania braziliensis and Leishmania amazonensis in the diagnosis and follow-up of mucosal leishmaniasis.
    Junqueira Pedras M; Orsini M; Castro M; Passos VM; Rabello A
    Diagn Microbiol Infect Dis; 2003 Nov; 47(3):477-85. PubMed ID: 14596966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of serological markers to monitor the disease status of Indian post kala-azar dermal leishmaniasis.
    Mukhopadhyay D; Das NK; De Sarkar S; Manna A; Ganguly DN; Barbhuiya JN; Maitra AK; Hazra A; Chatterjee M
    Trans R Soc Trop Med Hyg; 2012 Nov; 106(11):668-76. PubMed ID: 22920931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upgrading the flow-cytometric analysis of anti-Leishmania immunoglobulins for the diagnosis of American tegumentary leishmaniasis.
    Pissinate JF; Gomes IT; Peruhype-Magalhães V; Dietze R; Martins-Filho OA; Lemos EM
    J Immunol Methods; 2008 Jul; 336(2):193-202. PubMed ID: 18538785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral immune responses among mucosal and cutaneous leishmaniasis patients caused by Leishmania braziliensis.
    Valli LC; Passos VM; Dietze R; Callahan HL; Berman JD; Grogl M
    J Parasitol; 1999 Dec; 85(6):1076-83. PubMed ID: 10647040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?
    Gomes-Silva A; de Cássia Bittar R; Dos Santos Nogueira R; Amato VS; da Silva Mattos M; Oliveira-Neto MP; Coutinho SG; Da-Cruz AM
    Clin Exp Immunol; 2007 Sep; 149(3):440-4. PubMed ID: 17614975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American tegumentary leishmaniasis diagnosis using L. (V.) braziliensis fixed promastigotes: a comparative performance of serological tests and spontaneous cure identification.
    Mendes APO; Oliveira BC; Pereira AMS; Castro MCAB; Souza MA; Brito MEF; Araújo FF; Teixeira-Carvalho A; Martins-Filho OA; Pereira VRA
    BMC Infect Dis; 2019 Nov; 19(1):1015. PubMed ID: 31783798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a hypothetical protein for serodiagnosis and as a potential marker for post-treatment serological evaluation of tegumentary leishmaniasis patients.
    Lima MP; Costa LE; Duarte MC; Menezes-Souza D; Salles BCS; de Oliveira Santos TT; Ramos FF; Chávez-Fumagalli MA; Kursancew ACS; Ambrósio RP; Roatt BM; Machado-de-Ávila RA; Gonçalves DU; Coelho EAF
    Parasitol Res; 2017 Apr; 116(4):1197-1206. PubMed ID: 28150041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Leishmania IgG is a marker of disseminated leishmaniasis caused by Leishmania braziliensis.
    Magalhães A; Carvalho LP; Costa R; Pita MS; Cardoso TM; Machado PRL; Carvalho EM; Arruda S; Carvalho AM
    Int J Infect Dis; 2021 May; 106():83-90. PubMed ID: 33578011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
    Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
    Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure?
    Mendonça MG; de Brito ME; Rodrigues EH; Bandeira V; Jardim ML; Abath FG
    J Infect Dis; 2004 Mar; 189(6):1018-23. PubMed ID: 14999605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of IgG Anti-Leishmania Antigen by Flow Cytometry as a Diagnostic Test for Cutaneous Leishmaniasis.
    Pedral-Sampaio G; Alves JS; Schriefer A; Magalhães A; Meyer R; Glesby MJ; Carvalho EM; Carvalho LP
    PLoS One; 2016; 11(9):e0162793. PubMed ID: 27622535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.